| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/03/2001 | WO2001030980A2 Methods and compositions for enhancing developmental potential of oocytes and zygotes |
| 05/03/2001 | WO2001030978A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 05/03/2001 | WO2001030972A2 Regulation of gene expression by neuroleptic agents |
| 05/03/2001 | WO2001030970A2 Improved protocol for activation of oocytes |
| 05/03/2001 | WO2001030894A1 Novel carrier beads for cell culture bearing particular properties and production thereof |
| 05/03/2001 | WO2001030853A1 Antibody against rat postacrosome reaction sperm and utilization thereof |
| 05/03/2001 | WO2001030851A2 Idiotype vaccines |
| 05/03/2001 | WO2001030849A1 Dna molecules encoding l-glutamate-gated chloride channels from schistocerca americana |
| 05/03/2001 | WO2001030848A2 Nucleic acids of the human abc1 gene and applications thereof |
| 05/03/2001 | WO2001030847A1 Modified gp100 and uses thereof |
| 05/03/2001 | WO2001030846A1 Beta-defensins |
| 05/03/2001 | WO2001030845A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 05/03/2001 | WO2001030844A1 Dna encoding human alpha1g-c t-type calcium channel |
| 05/03/2001 | WO2001030843A1 Ligand activated transcriptional regulator proteins |
| 05/03/2001 | WO2001030828A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2) |
| 05/03/2001 | WO2001030812A2 Activation of hcv-specific t cells |
| 05/03/2001 | WO2001030798A1 Transgenic mice containing trp gene disruptions |
| 05/03/2001 | WO2001030754A2 Micro-cluster liquids and methods of making and using them |
| 05/03/2001 | WO2001030394A1 Treatment of cancer |
| 05/03/2001 | WO2001030382A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/03/2001 | WO2001030369A1 Process for inducing immunological tolerance for xenogeneic transplants |
| 05/03/2001 | WO2001030360A1 Modulation of l-selectin shedding via inhibition of tumor necrosis factor alpha converting enzyme (tace) |
| 05/03/2001 | WO2001014530A3 Method for growing stem cells |
| 05/03/2001 | WO2001002553A3 Dna binding protein and sequence as insulators having specific enhancer blocking activity for regulation of gene expression |
| 05/03/2001 | WO2000078802A3 Secreted polypeptides and corresponding polynucleotides |
| 05/03/2001 | WO2000077214A3 Characterization of the yeast transcriptome |
| 05/03/2001 | WO2000077168A3 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS |
| 05/03/2001 | WO2000076537A3 Use of semi-allogeneic cell line-peptide complexes for the treatment of cancer, aids and other viral diseases |
| 05/03/2001 | WO2000075286A3 3-dimensional in vitro models of mammaliam tissues |
| 05/03/2001 | WO2000073431A3 Methods and compositions for measuring ion channel conductance |
| 05/03/2001 | WO2000068263A3 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 05/03/2001 | US20010000804 Tissue decellularization |
| 05/03/2001 | US20010000802 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 05/03/2001 | DE19949179A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid |
| 05/03/2001 | DE10039856A1 Inducing cell replication in resting cells, useful for producing cells for e.g. toxicology testing, by transient expression of immortalizing gene |
| 05/03/2001 | CA2721011A1 Modified gp100 and uses thereof |
| 05/03/2001 | CA2426669A1 .alpha.1-3 galactosyltransferase gene and promoter |
| 05/03/2001 | CA2389522A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | CA2389256A1 Beta-defensins |
| 05/03/2001 | CA2389127A1 Human sphingosine kinase gene |
| 05/03/2001 | CA2389121A1 Olfactory ensheathing cells isolated from the lamina propria |
| 05/03/2001 | CA2389117A1 Methods and compositions for enhancing developmental potential of oocytes and zygotes |
| 05/03/2001 | CA2389110A1 Regulation of gene expression by neuroleptic agents |
| 05/03/2001 | CA2389031A1 Dna encoding human alpha1g-c t-type calcium channel |
| 05/03/2001 | CA2388998A1 Treatment of cancer |
| 05/03/2001 | CA2388950A1 Nucleic acids of the human abc1 gene and their therapeutic and diagnostic application |
| 05/03/2001 | CA2388942A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2) |
| 05/03/2001 | CA2388934A1 Micro-cluster liquids and methods of making and using them |
| 05/03/2001 | CA2388637A1 Human fgf-20 gene and gene expression products |
| 05/03/2001 | CA2388617A1 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/03/2001 | CA2388599A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | CA2388535A1 Ligand activated transcriptional regulator proteins |
| 05/03/2001 | CA2388422A1 Heterologous production of polyketides |
| 05/03/2001 | CA2388337A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/03/2001 | CA2388332A1 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 05/03/2001 | CA2388162A1 Dna molecules encoding l-glutamate-gated chloride channels from schistocerca americana |
| 05/03/2001 | CA2388149A1 Human homologue of yeast helicase and uses thereof |
| 05/03/2001 | CA2387907A1 Serum amyloid a isoform from colostrum |
| 05/03/2001 | CA2387691A1 Novel enzyme |
| 05/03/2001 | CA2387680A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 05/03/2001 | CA2387506A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 05/03/2001 | CA2387378A1 Processed human chemokines phc-1 and phc-2 |
| 05/03/2001 | CA2386509A1 G protein-coupled receptors expressed in human brain |
| 05/02/2001 | EP1096162A1 Split spool type flexible coupling |
| 05/02/2001 | EP1096018A1 Complementation cells comprising an inducer and/or a repressor |
| 05/02/2001 | EP1096017A2 Method for increasing the production of physiologically active substances by cultured cells |
| 05/02/2001 | EP1096016A1 Platelet-activating factor acetylhydrolase |
| 05/02/2001 | EP1096015A2 Method for cloning and expression of the NheI restriction endonuclease in E. coli |
| 05/02/2001 | EP1096014A2 Catalytic domain of the human effector cell cycle checkpoint protein kinase, Chk1, materials and methods for identification of inhibitors thereof |
| 05/02/2001 | EP1096009A1 G-protein coupled receptor-like Polypeptide |
| 05/02/2001 | EP1096008A2 Human G protein-coupled receptor, PFI-014 |
| 05/02/2001 | EP1095967A1 Novel cell culture supports carrying special properties and their production |
| 05/02/2001 | EP1095948A1 Idiotype vaccines |
| 05/02/2001 | EP1095159A1 Bone morphogenic protein |
| 05/02/2001 | EP1095154A2 Interaction of human beta amyloid precursor protein (beta-app) with human lon-protease like protein (hslon) |
| 05/02/2001 | EP1095152A2 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch |
| 05/02/2001 | EP1095151A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 05/02/2001 | EP1095149A2 Compositions and methods for fumonisin detoxification |
| 05/02/2001 | EP1095148A2 Cloning and characterisation of novel mammalian peptidases |
| 05/02/2001 | EP1095145A1 Pathogen-resistant grape plants |
| 05/02/2001 | EP1095144A2 Enhancer elements for increased translation in plant plastids |
| 05/02/2001 | EP1095142A2 Molecules associated with cell proliferation |
| 05/02/2001 | EP1095140A2 Neurotrophic factors |
| 05/02/2001 | EP1095137A1 Novel promoter sequences of myostatin gene |
| 05/02/2001 | EP1095136A1 Cells and animals deficient in protein kinase c epsilon |
| 05/02/2001 | EP1095133A1 Ftsz multimeric proteins and their uses |
| 05/02/2001 | EP1095132A1 Methods for implanting cells |
| 05/02/2001 | EP1095060A1 Galectin 11 |
| 05/02/2001 | EP1095002A1 Method of vitamin production |
| 05/02/2001 | EP1094829A2 Methods for accelerating bone and cartilage growth and repair |
| 05/02/2001 | EP1094806A2 Vasculoprotector |
| 05/02/2001 | EP1094703A2 Improved methods for storing neural cells |
| 05/02/2001 | EP1006801A4 Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders |
| 05/02/2001 | EP0817860B1 Pseudotyped retroviral particles |
| 05/02/2001 | EP0814819A4 Sertoli cells as transplantation facilitator for cell transplantation |
| 05/02/2001 | CN1293711A Genes encoding MLO proteins and conferring fungal resistance upon plants |
| 05/02/2001 | CN1293709A Identification of factors which mediate the interaction of heterotrimeric G proteins and monomeric G proteins |
| 05/02/2001 | CN1293707A Development of normal offspring from oocytes injected with freeze-bried spermatozoa |
| 05/02/2001 | CA2288441A1 Method for propagation of insecta germ cells |
| 05/01/2001 | US6225536 Nucleotide sequences from preferential ovules or fibers of plants; for the generation of plants with amplified fiber length, fineness and strength |